Evidence map›Paper›PMID 41184381›Full record

ArticleScientific reports2025

Enhanced skin cancer classification using modified efficientNetV2L with adaptive early stopping mechanism.

Chandrasekar Venkatachalam, Shanmugavalli Venkatachalam, Arunkumar Balakrishnan

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chandrasekar VenkatachalamDepartment of Computer Science and Engineering, Faculty of Engineering, Jain (Deemed to be university), Bangalore, 562112, Karnataka, India.
Shanmugavalli VenkatachalamManipal Institute of Technology Bengaluru, Manipal Academy of Higher Education, Manipal, India. shanmugavalli.v@manipal.edu.
Arunkumar BalakrishnanManipal Institute of Technology Bengaluru, Manipal Academy of Higher Education, Manipal, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The accurate classification of skin cancer types is a critical task in medical diagnostics, requiring robust and reliable models to distinguish between various skin lesions. Despite advancements in deep learning, developing models that generalize well to unseen data remains a challenge. Current methodologies primarily utilize convolutional neural networks (CNNs) for image classification tasks, leveraging architectures such as ResNet, VGG, and Inception. These models have shown promise in improving classification accuracy for skin cancer detection. However, existing models often face limitations, including overfitting to the training data and difficulty in handling imbalanced datasets. This results in decreased performance on validation and test datasets, reducing their practical applicability in clinical settings. Additionally, these models may lack the fine-grained discrimination required to accurately classify a diverse range of skin lesion types. To address the limitations of traditional CNN-based approaches, we propose a novel model based on the EfficientNetV2L architecture, optimized for skin lesion classification. Our approach introduces adaptive early stopping and learning rate callbacks to enhance generalization and prevent overfitting. Trained on the ISIC dataset, the model achieved a high classification accuracy of 99.22%, demonstrating robustness across various lesion types. This work contributes a powerful, efficient, and clinically relevant solution to the field of automated skin cancer diagnosis.

Indexed as

Neural Networks, ComputerSkin NeoplasmsAlgorithmsDeep LearningHumansMelanomaCallback mechanismDeep learningEarlystoppingEfficientNetV2LSkin cancer classification

Identifiers

PMID41184381
PMCPMC12583686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.